Trial · NCT03436615
Results by group110
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 110
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Subjects Achieving Complete Clearance at Week 12 | Cohort 1: SB206 4% BID | 5 | Participants | ||
| Proportion of Subjects Achieving Complete Clearance at Week 12 | Cohort 2: SB206 8% BID | 16 | Participants | ||
| Proportion of Subjects Achieving Complete Clearance at Week 12 | Cohort 3: SB206 12% BID | 13 | Participants | ||
| Proportion of Subjects Achieving Complete Clearance at Week 12 | Cohort 4: SB206 12% QD | 18 | Participants | ||
| Proportion of Subjects Achieving Complete Clearance at Week 12 | Placebo (Vehicle Gel) | 12 | Participants | ||
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 1: SB206 4% BID | Week 1 proportion of subjects achieving complete clearance. | 0 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 2: SB206 8% BID | Week 1 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 3: SB206 12% BID | Week 1 proportion of subjects achieving complete clearance. | 0 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 4: SB206 12% QD | Week 1 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Placebo (Vehicle Gel) | Week 1 proportion of subjects achieving complete clearance. | 0 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 1: SB206 4% BID | Week 2 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 2: SB206 8% BID | Week 2 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 3: SB206 12% BID | Week 2 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 4: SB206 12% QD | Week 2 proportion of subjects achieving complete clearance. | 3 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Placebo (Vehicle Gel) | Week 2 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 1: SB206 4% BID | Week 4 proportion of subjects achieving complete clearance. | 1 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 2: SB206 8% BID | Week 4 proportion of subjects achieving complete clearance. | 3 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 3: SB206 12% BID | Week 4 proportion of subjects achieving complete clearance. | 3 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Cohort 4: SB206 12% QD | Week 4 proportion of subjects achieving complete clearance. | 5 | participants | |
| Proportion of Subjects Achieving Complete Clearance at Each Visit | Placebo (Vehicle Gel) | Week 4 proportion of subjects achieving complete clearance. | 2 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03436615/results